23Mofang
PrivateLast Round
VC Round
Aug 26, 2020
Est. Valuation
$74M
Total Funding Raised
$36.43M
Company Overview
23Mofang operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a VC Round in August 2020.
23Mofang is a biotechnology company that provides direct-to-consumer genetic testing services, offering insights into ancestry, hereditary disease risks, and genetic traits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
23Mofang Comparables
Compare 23Mofang with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WeGene | 93% | |
| Genebox | 89% | |
| GeseDNA Technology | 85% |
For institutional investors. Book with your work email.
23Mofang Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 26, 2020 | ||||
| Series B Extension | May 31, 2018 | ||||
| Series B Extension | Mar 6, 2018 | ||||
| Series B | Aug 2, 2017 | ||||
| Series A | Jan 3, 2017 | ||||
Pre Seed | Jan 12, 2016 |
For institutional investors. Book with your work email.
23Mofang Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fenghou Capital | Series B, Pre Seed, Angel |
| Bencao Capital | Series B Extension |
| 奇点资本 | Pre Seed |
| MPC | Series B Extension |
| Banyan Pacific Capital | Series B Extension |
| SB China Capital | Series B Extension |
| CD Capital | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2020
Pansheng Asset Management participated in the round.
- May 30, 2018
Raised $9.67M led by CD Capital.
For institutional investors. Book with your work email.
23Mofang Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 23Mofang's valuation, stock price, and market status.
Is 23Mofang a public or private company?
23Mofang is a private company.
What is the current stock price of 23Mofang?
23Mofang is a private company, so its shares have no public market price. Caplight tracks 23Mofang's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 23Mofang worth (valuation)?
23Mofang's valuation is estimated at $74.0M based on funding round data.
Can I buy 23Mofang stock?
23Mofang shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 23Mofang's last funding round?
23Mofang's most recent funding round was VC Round on August 26, 2020.
Who are the main investors in 23Mofang?
Key investors in 23Mofang include Fenghou Capital, MPC, CD Capital.
Will 23Mofang IPO soon?
No public IPO plans have been announced for 23Mofang.
How can I track 23Mofang secondary market activity?
Caplight tracks bids, offers, and trades in 23Mofang's shares on secondary markets.